Biotech

All Articles

Oncternal equity drains 60% amid discharges, test terminations

.Cancer cells firm Oncternal Therapeutics is actually folding all its medical trials and also laying...

Roche is supporting out chances that its injectable being overweight prospect might inevitably show 25% weight reduction in late-stage test

.Roche is keeping out hopes that its own injectable being overweight possibility can inevitably illu...

Novo Nordisk hails 'remarkable' weight loss lead for dual-acting dental medication in early test

.Novo Nordisk has actually lifted the cover on a stage 1 test of its oral amylin and also GLP-1 rece...

AbbVie sues BeiGene over blood cancer medicine proprietary knowledge

.Simply a couple of short full weeks after succeeding an FDA Fast lane tag for its own investigation...

Lilly provides one-two blow with second tranche of beneficial data on every week insulin candidate

.Not long after a favorable records reduce for Eli Lilly's efsitora alfa, the Indianapolis-based fir...

BridgeBio reduces gene treatment budget plan as clinical information disappoint

.BridgeBio Pharma is actually lowering its own gene therapy spending plan and also drawing back comi...

GSK gives up HSV vaccine wishes after stage 2 stop working, delivering ethnicity to Moderna, BioNTech

.GSK's effort to establish the first vaccine for herpes simplex virus (HSV) has actually finished in...

GSK's long-acting breathing problem medication halved assaults in stage 3

.GSK's long-acting asthma therapy has actually been actually revealed to cut in half the variety of ...

AstraZeneca, Daiichi unbox Dato-DXd's overall survival fall short

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually stopped ...

Roivant introduces brand new 'vant' to evolve Bayer high blood pressure med

.Matt Gline is actually back with a brand-new 'vant' provider, after the Roivant Sciences CEO spent ...